By Chris Wack 60 Degrees Pharmaceuticals said that following a Type C meeting held Wednesday with the Food and Drug Administration, it will move forward with.
By Chris Wack 60 Degrees Pharmaceuticals shares were up 18% to 74 cents after the company said it will move forward with a pivotal clinical study of tafenoquine in hospitalized babesiosis.
WASHINGTON, Jan. 16, 2024 60 Degrees Pharmaceuticals, Inc. , a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that on January 10, 2024 it.
Wall Street Breakfast: The Week Ahead seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Stocks To Watch: Inflation Data + Big Conferences in Tech, Retail And Healthcare seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.